Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. ROYCE RIFAMPICIN CAPSULE 150MG [SIN16652P]

ROYCE RIFAMPICIN CAPSULE 150MG [SIN16652P]

Active ingredients: ROYCE RIFAMPICIN CAPSULE 150MG

Last updated 26 October 2025

Product Info

ROYCE RIFAMPICIN CAPSULE 150MG

[SIN16652P]

Product information

Active Ingredient and Strength

RIFAMPICIN - 150 MG

Dosage Form

CAPSULE

Manufacturer and Country

ROYCE PHARMA MANUFACTURING SDN. BHD. - MALAYSIA

Registration Number

SIN16652P

Licence Holder

GOLDPLUS UNIVERSAL PTE LTD

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

J04AB02

Indication :
Royce Rifampicin Capsule used in combination with other active antituberculosis drugs is indicated in the treatment of all forms of tuberculosis. It is also effective against many atypical strains of mycobacteria.

Dosage and Administration :
Royce Rifampicin should be given as a single dose before meals to ensure rapid and complete absorption. Dosage should be adjusted according to body weight of patients.
Adults : 450 – 600mg daily as a single dose (based on approximately 10mg per kg body weight). Those patients 50 kg and over should take 600mg daily, whilst patients under 50 kg should take 450mg.
Children: Up to 20mg per kg body weight daily to a maximum of 600mg as a single dose.
Premature and newborn infants : 10mg/kg once daily.

Royce Rifampicin should be given with other effective antituberculosis drugs to prevent the possible emergence of rifampicin-resistant strains of mycobacteria.

Contraindication :
Jaundice; hypersensitivity to Rifampicin antibiotics; first trimester of pregnancy; premature and newborn infants; are concurrently receiving saquinavir/ritonavir therapy.